ACQUISITIONS (Details) $ in Thousands		3 Months Ended		9 Months Ended		12 Months Ended
	May. 30, 2014 USD ($) patent	Sep. 30, 2015 USD ($)	Sep. 30, 2014 USD ($)	Sep. 30, 2015 USD ($)	Sep. 30, 2014 USD ($)	Dec. 31, 2014 USD ($)
Total purchase price allocation
Asset retirement obligation		$ (53)		$ (53)		$ (348)
Bargain purchase gain		0	$ 0	0	$ (3,634)
Identifiable intangible assets acquired and their estimated useful lives
Restructuring expenses		$ 100		$ 3,100
CTRM Business
Acquisitions
Number of patents and patents applications acquired | patent	250
Total purchase price consideration
Cash payment	$ 4,000
Promissory note	2,500
Total acquisition consideration	6,500
Total purchase price allocation
Cash	5,050
Accounts receivable	53
Inventory	2,039
Other current assets	192
Accounts payable and accrued expenses	(939)
Asset retirement obligation	(1,600)
Property and equipment	1,818
Intangible assets	3,360
Bargain purchase gain	(3,473)
Total consideration	$ 6,500
Identifiable intangible assets acquired and their estimated useful lives
Restructuring expenses						$ 3,000
CTRM Business | Commercial rights
Identifiable intangible assets acquired and their estimated useful lives
Useful Life	12 years
CTRM Business | Sanofi | Denmark
Identifiable intangible assets acquired and their estimated useful lives
Cash received in order to fund the restructuring of the Denmark operations and close the facility	$ 5,000